Nawaaz A Nathoo1, Steve Rasmussen2, Peter J Dolman3, David W Rossman3. 1. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, B.C.. Electronic address: nawaaz@ualberta.ca. 2. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, B.C.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, B.C. 3. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, B.C.
Abstract
OBJECTIVE: To describe findings in patients who received dermal fillers and later developed peri-ocular mass lesions. DESIGN: Retrospective case series. PARTICIPANTS: Patients who presented with peri-ocular masses secondary to dermal filler use. METHODS: Retrospective chart review. RESULTS: Three patients with remote filler injection (hyaluronic acid and polyalkylimide), not volunteered on initial history, presented with peri-orbital swelling and/or inflammation that was suspicious in each case for more serious pathology. CONCLUSIONS: It is important for the injecting physician, the ophthalmologist, and the patient to recognize this complication to permit appropriate investigation and management.
OBJECTIVE: To describe findings in patients who received dermal fillers and later developed peri-ocular mass lesions. DESIGN: Retrospective case series. PARTICIPANTS: Patients who presented with peri-ocular masses secondary to dermal filler use. METHODS: Retrospective chart review. RESULTS: Three patients with remote filler injection (hyaluronic acid and polyalkylimide), not volunteered on initial history, presented with peri-orbital swelling and/or inflammation that was suspicious in each case for more serious pathology. CONCLUSIONS: It is important for the injecting physician, the ophthalmologist, and the patient to recognize this complication to permit appropriate investigation and management.
Authors: Soo Yuhl Chae; Kyou Chae Lee; Yong Hyun Jang; Seok-Jong Lee; Do Won Kim; Weon Ju Lee Journal: Ann Dermatol Date: 2016-09-30 Impact factor: 1.444